Ad Insights | Evolving Landscape for Managing Cardiovascular, Renal and Metabolic Conditions

Boehringer Ingelheim's Brian Hilberdink, President, U.S. Human Pharma, and Neerja Balachander, M.D., Ph.D., VP, U.S. Clinical Development Medical Affairs and Cardiorenal Metabolic Therapeutic Area Head, reflect on key developments and what lies ahead for cardiovascular, renal and metabolic care, including implications for obesity, liver disease and chronic kidney disease.

Raccontata damedpagetoday.com